Epsilon M&A Deal Report - artus
Transaction Multiples for the Valuation of Private Companies
Qiagen / artus
No EMAT :
16405
Announced Date :
31/05/2005
Type :
Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Qiagen
Target :
artus
Country :
Germany
Sector of activity :
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Pharmaceuticals
- Health, Pharmaceuticals & Biotechnology > Biotechnology
Business Description :
Was established by six scientists as a spin-off of the Bernhard-Nocht-Institute for Tropical Medicine in Hamburg in 1998 > Manufactures molecular diagnostic tests for pathogenenic, genotyping and...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|||||||
| Current |
|
Rating :
*
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Pharmaceuticals » = 133
- Number of EMAT Reports / sub-sector « Biotechnology » = 46
| Date | Acquirer | Target | Country | Multiples | See details |
| 13/03/2006 | Sinclair Pharma | Groupe CS Dermatologie | France | ** | 16401 |
| 17/01/2005 | Recordati | Branded Pharmaceutical Business of Merckle | Germany | ** | 16370 |
Source: Epsilon Research / EMAT
